	doi	entity	effect	level
0	10.1101/2022.02.07.22270437	delta	infectivity	undefined
1	10.3389/fmed.2021.780611	delta	infectivity	higher
2	10.3390/v14040783	delta	infectivity	undefined
3	10.3390/v14040783	omicron	infectivity	undefined
4	10.1101/2022.02.02.22269653	delta	infectivity	higher
5	10.3760/cma.j.cn112338-20210808-00619	delta	infectivity	higher
6	10.1073/pnas.2116518119	delta	infectivity	higher
7	10.1016/j.puhe.2022.01.005	delta	infectivity	undefined
8	10.3390/ijms22168714	SPIKE_D614G	protein_stability	higher
9	10.3390/ijms22168714	SPIKE_D614A-C	protein_stability	higher
10	10.1128/msphere.00104-21	SPIKE_D614G	infectivity	higher
11	10.1128/msphere.00104-21	SPIKE_G614	infectivity	higher
12	10.1128/msphere.00104-21	SPIKE_SSPIKE_S614+SPIKE_G614	infectivity	higher
13	10.3390/v13061098	B.1.1.7	sensitivity_to_mAbs	lower
14	10.3390/v13061098	B.1.1.1.7	sensitivity_to_mAbs	lower
15	10.3390/v13061098	VOC	sensitivity_to_mAbs	lower
16	10.1007/s10989-021-10346-1	SPIKE_N501Y	binding_to_host_receptor	higher
17	10.1007/s10989-021-10346-1	SPIKE_N501Y	sensitivity_to_vaccine_sera	lower
18	10.1007/s10989-021-10346-1	SPIKE_N501Y	sensitivity_to_other_diseases	higher
19	10.1007/s10989-021-10346-1	SPIKE_P681H	binding_to_host_receptor	higher
20	10.1007/s10989-021-10346-1	SPIKE_P681H	sensitivity_to_vaccine_sera	lower
21	10.1007/s10989-021-10346-1	SPIKE_P681H	sensitivity_to_other_diseases	higher
22	10.3201/eid2705.210191	E484K	effectiveness_of_available_diagnostics	lower
23	10.3201/eid2705.210191	PV_E484K	effectiveness_of_available_diagnostics	lower
24	10.3201/eid2705.210191	E484K	effectiveness_of_available_diagnostics	lower
25	10.3201/eid2705.210191	PV_N484K	effectiveness_of_available_diagnostics	lower
26	10.1371/journal.ppat.1009929	NSP12_E802D	effectiveness_of_available_antiviral_drugs	lower
27	10.1371/journal.ppat.1009929	NSP12_N501	effectiveness_of_available_antiviral_drugs	lower
28	10.1371/journal.ppat.1009929	SP12_E484	effectiveness_of_available_antiviral_drugs	lower
29	10.1371/journal.ppat.1009929	NSP12_H655	effectiveness_of_available_antiviral_drugs	lower
30	10.1371/journal.ppat.1009929	NSP12_N501+SP12_N501	effectiveness_of_available_antiviral_drugs	lower
31	10.3390/jdb9040058	delta	infectivity	higher
32	10.1021/acs.jpclett.1c01415	SPIKE_E484K	binding_to_Abs	lower
33	10.1021/acs.jpclett.1c01415	SPIKE_E484K	sensitivity_to_vaccine_sera	lower
34	10.1021/acs.jpclett.1c01415	SPIKE_E484K	viral_transmission	higher
35	10.1021/acs.jpclett.1c01415	SPIKE_K417N	infectivity	undefined
36	10.1021/acs.jpclett.1c01415	SPIKE_N501Y	infectivity	undefined
37	10.1021/acs.jpclett.1c01415	SPIKE_E484K	binding_to_Abs	lower
38	10.1021/acs.jpclett.1c01415	SPIKE_E484K	sensitivity_to_vaccine_sera	lower
39	10.1021/acs.jpclett.1c01415	SPIKE_E484K	viral_transmission	higher
40	10.1021/acs.jpclett.1c01415	SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y	infectivity	undefined
41	10.1002/jcp.30367	SPIKE_E484K+SPIKE_N501Y	infectivity	undefined
42	10.1038/s41467-022-28768-w	SPIKE_D614G	binding_to_host_receptor	higher
43	10.1038/s41467-022-28768-w	SPIKE_K417N	binding_to_host_receptor	higher
44	10.1038/s41467-022-28768-w	SPIKE_N501Y	binding_to_host_receptor	higher
45	10.1038/s41467-022-28768-w	B.1.351	binding_to_host_receptor	higher
46	10.1038/s41467-022-28768-w	B.1.1.7	binding_to_host_receptor	higher
47	10.1016/j.ygeno.2021.05.006	SPIKE_E484Q	infectivity	higher
48	10.1016/j.ygeno.2021.05.006	SPIKE_E484Q	viral_transmission	higher
49	10.1016/j.ygeno.2021.05.006	SPIKE_K417N	infectivity	higher
50	10.1016/j.ygeno.2021.05.006	SPIKE_K417N	viral_transmission	higher
51	10.1016/j.ygeno.2021.05.006	SPIKE_E484Q	infectivity	higher
52	10.1016/j.ygeno.2021.05.006	SPIKE_E484Q	viral_transmission	higher
53	10.1016/j.ygeno.2021.05.006	SPIKE_A475S	infectivity	higher
54	10.1016/j.ygeno.2021.05.006	SPIKE_A475S	viral_transmission	higher
55	10.1016/j.ygeno.2021.05.006	B.1.1.222	infectivity	higher
56	10.1016/j.ygeno.2021.05.006	B.1.1.222	viral_transmission	higher
57	10.1080/07391102.2021.1908170	NSP3+N_P344S+SPIKE_D614G	protein_flexibilty	undefined
58	10.1101/2021.03.31.437666	Q57H	complication_with_other_diseases	higher
59	10.1101/2021.03.31.437666	P160I	complication_with_other_diseases	higher
60	10.1101/2021.03.31.437666	Q57H+SPIKE_NSPIKE_VUI+SPIKE_Y.V2	complication_with_other_diseases	higher
61	10.1002/jmv.26626	N_R203K+N_G204R	effectiveness_of_available_vaccines	lower
62	10.3389/fgene.2020.612571	SPIKE_D614G	protein_flexibilty	undefined
63	10.3389/fgene.2020.612571	SPIKE_P4715L	protein_flexibilty	undefined
64	10.3389/fgene.2020.612571	SPIKE_P+SPIKE_N+SPIKE_G1167V	sensitivity_to_vaccine_sera	lower
65	10.3389/fgene.2020.612571	SPIKE_P+SPIKE_N+SPIKE_G1167V	viral_transmission	undefined
66	10.1101/2020.08.05.237339	N_R203K+N_G204R	effectiveness_of_available_vaccines	lower
67	10.1101/2022.01.13.22269211	omicron	complication_with_other_diseases	undefined
68	10.1101/2022.02.25.22271511	BA.2	effectiveness_of_available_vaccines	lower
69	10.1101/2022.02.25.22271511	BA.1+VOC	effectiveness_of_available_vaccines	lower
70	10.1016/j.ijid.2022.02.051	omicron	complication_with_other_diseases	higher
71	10.1101/2022.03.10.22272196	omicron	complication_with_other_diseases	undefined
72	10.1002/ctd2.22	omicron	effectiveness_of_available_diagnostics	lower
73	10.1038/s41421-022-00401-6	delta	infectivity	higher
74	10.1002/rmv.2277	B.1.351	effectiveness_of_available_vaccines	lower
75	10.1002/rmv.2277	P.1+P.1.617.2	effectiveness_of_available_vaccines	lower
76	10.1128/mbio.00099-22	delta	sensitivity_to_convalescent_sera	lower
77	10.1128/mbio.00099-22	delta	sensitivity_to_vaccine_sera	lower
78	10.1128/mbio.00099-22	delta	binding_to_Abs	lower
79	10.1128/mbio.00099-22	B.1.618	binding_to_Abs	lower
80	10.1128/mbio.00099-22	B.1.618	sensitivity_to_convalescent_sera	lower
81	10.1128/mbio.00099-22	B.1.618	binding_to_Abs	lower
82	10.1128/mbio.00099-22	SPIKE_E484K	binding_to_Abs	lower
83	10.1128/mbio.00099-22	SPIKE_E484K	sensitivity_to_convalescent_sera	lower
84	10.1128/mbio.00099-22	SPIKE_E484K	sensitivity_to_vaccine_sera	lower
85	10.1128/mbio.00099-22	P681R	binding_to_Abs	lower
86	10.1128/mbio.00099-22	P681R	sensitivity_to_convalescent_sera	lower
87	10.1128/mbio.00099-22	P681R	binding_to_Abs	lower
88	10.1128/mbio.00099-22	B.1.617.2	binding_to_Abs	lower
89	10.1128/mbio.00099-22	B.1.617.2	sensitivity_to_convalescent_sera	lower
90	10.1128/mbio.00099-22	B.1.617.2	sensitivity_to_vaccine_sera	lower
91	10.1128/mbio.00099-22	B.1.617.2	binding_to_Abs	lower
92	10.1016/j.chom.2021.04.007	P.1	sensitivity_to_vaccine_sera	lower
93	10.1016/j.chom.2021.04.007	P.1	sensitivity_to_vaccine_sera	lower
94	10.1016/j.chom.2021.04.007	P.1	sensitivity_to_other_diseases	lower
95	10.1101/2021.12.14.472630	omicron	effectiveness_of_available_vaccines	lower
96	10.1080/22221751.2021.2008775	SPIKE_L452Q+SPIKE_F490S	infectivity	undefined
97	10.1080/22221751.2021.2008775	SPIKE_L452Q+SPIKE_F490S	infectivity	undefined
98	10.1080/22221751.2021.2008775	SPIKE_F490S+SPIKE_F490S	infectivity	undefined
99	10.1080/22221751.2021.2008775	SPIKE_L452Q+SPIKE_F490S+SPIKE_F490S	infectivity	undefined
100	10.1101/2021.01.07.425705	SPIKE_D614G	effectiveness_of_available_vaccines	lower
101	10.1101/2021.01.07.425705	SPIKE_D614G+SPIKE_Q57H	effectiveness_of_available_vaccines	lower
102	10.1101/2021.01.07.425705	SPIKE_A222V	effectiveness_of_available_vaccines	lower
103	10.21203/rs.3.rs-681182/v1	SPIKE_N501Y	infectivity	undefined
104	10.21203/rs.3.rs-681182/v1	SPIKE_D614G+SPIKE_A222V+SPIKE_N751Y	infectivity	undefined
105	10.21203/rs.3.rs-681182/v1	SPIKE_N501Y+SPIKE_A222V+SPIKE_N501Y	infectivity	undefined
106	10.1101/2021.05.24.21257705	P618H+P1230L+V1230L+SPIKE_E484K	infectivity	higher
107	10.1101/2021.05.24.21257705	P618H+P1230L+V1230L+SPIKE_E484K	sensitivity_to_vaccine_sera	lower
108	10.1101/2021.05.24.21257705	P618H+P1230L+SPIKE_E484K	infectivity	higher
109	10.1101/2021.05.24.21257705	P618H+P1230L+SPIKE_E484K	sensitivity_to_vaccine_sera	lower
110	10.1101/2021.05.24.21257705	P618H+P1230L+SPIKE_V1230L+SPIKE_E484K	infectivity	higher
111	10.1101/2021.05.24.21257705	P618H+P1230L+SPIKE_V1230L+SPIKE_E484K	sensitivity_to_vaccine_sera	lower
112	10.1002/jmv.27418	B.1.1.318	infectivity	undefined
113	10.1186/s40249-021-00895-4	SPIKE_E484K	infectivity	higher
114	10.1186/s40249-021-00895-4	SPIKE_N354D	infectivity	higher
115	10.1186/s40249-021-00895-4	SPIKE_V367F	infectivity	higher
116	10.1186/s40249-021-00895-4	SPIKE_E484K	infectivity	higher
117	10.1128/mBio.02510-21	B.1.351	sensitivity_to_mAbs	lower
118	10.1128/mBio.02510-21	P1-501Y-V3	infectivity	higher
119	10.1128/mBio.02510-21	SPIKE_Q677H	sensitivity_to_vaccine_sera	lower
120	10.1128/mBio.02510-21	SPIKE_Q677H	sensitivity_to_other_vaccine_sera	lower
121	10.1128/mBio.02510-21	B.1.1.7	sensitivity_to_mAbs	lower
122	10.1101/2021.05.26.445838	B.1.617.2	effectiveness_of_available_vaccines	lower
123	10.1016/j.jemep.2021.100722	delta	complication_with_other_diseases	higher
124	10.1101/2022.02.09.479840	delta	effectiveness_of_available_antiviral_drugs	lower
125	10.1001/jama.2021.5607	B.1.1.7	effectiveness_of_available_diagnostics	lower
126	10.1101/2021.07.23.21260716	delta	complication_with_other_diseases	higher
127	10.1101/2021.03.04.433970	SPIKE_E484K+SPIKE_K417N+SPIKE_N501Y	binding_to_Abs	lower
128	10.1101/2021.03.04.433970	SPIKE_E484K+SPIKE_K417N+SPIKE_N501Y	sensitivity_to_vaccine_sera	lower
129	10.1101/2021.03.04.433970	SPIKE_E484K+SPIKE_K417N+SPIKE_N501Y	sensitivity_to_other_diseases	lower
130	10.1101/2021.03.04.433970	SPIKE_E484K+SPIKE_K417N+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y	binding_to_Abs	lower
131	10.1101/2021.03.04.433970	SPIKE_E484K+SPIKE_K417N+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y	sensitivity_to_vaccine_sera	lower
132	10.1101/2021.03.04.433970	SPIKE_E484K+SPIKE_K417N+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y+SPIKE_N501Y	sensitivity_to_other_diseases	lower
133	10.1093/bib/bbab383	SPIKE_E484K	binding_to_Abs	lower
134	10.1093/bib/bbab383	SPIKE_E484K	sensitivity_to_vaccine_sera	lower
135	10.1093/bib/bbab383	SPIKE_E484K	sensitivity_to_other_diseases	lower
136	10.1093/bib/bbab383	SPIKE_K484	binding_to_Abs	lower
137	10.1093/bib/bbab383	SPIKE_K484	sensitivity_to_vaccine_sera	lower
138	10.1093/bib/bbab383	SPIKE_K484	sensitivity_to_other_diseases	lower
139	10.1093/bib/bbab383	SPIKE_E484K	binding_to_Abs	lower
140	10.1093/bib/bbab383	SPIKE_E484K	sensitivity_to_vaccine_sera	lower
141	10.1093/bib/bbab383	SPIKE_E484K	sensitivity_to_other_diseases	lower
142	10.1093/bib/bbab383	SPIKE_K484+SPIKE_N484K	binding_to_Abs	lower
143	10.1093/bib/bbab383	SPIKE_K484+SPIKE_N484K	sensitivity_to_vaccine_sera	lower
144	10.1093/bib/bbab383	SPIKE_K484+SPIKE_N484K	sensitivity_to_other_diseases	lower
145	10.1093/bib/bbab383	SPIKE_N484K+SPIKE_N484K	binding_to_Abs	lower
146	10.1093/bib/bbab383	SPIKE_N484K+SPIKE_N484K	sensitivity_to_vaccine_sera	lower
147	10.1093/bib/bbab383	SPIKE_N484K+SPIKE_N484K	sensitivity_to_other_diseases	lower
148	10.1093/bib/bbab383	SPIKE_E484K+SPIKE_N484K	binding_to_Abs	lower
149	10.1093/bib/bbab383	SPIKE_E484K+SPIKE_N484K	sensitivity_to_vaccine_sera	lower
150	10.1093/bib/bbab383	SPIKE_E484K+SPIKE_N484K	sensitivity_to_other_diseases	lower
151	10.3126/nje.v11i1.35659	B.1.351	infectivity	undefined
152	10.3126/nje.v11i1.35659	P.1+VUI202101/01	infectivity	undefined
153	10.3126/nje.v11i1.35659	B.1.1.7	infectivity	undefined
154	10.3126/nje.v11i1.35659	B.1.1.7+VUI202101/01	infectivity	undefined
155	10.1002/jmv.27585	omicron	infectivity	higher
